非糖甜味剂摄入与健康结局关联的系统综述与荟萃分析
该系统综述纳入56项研究(含35项观察性研究),评估一般健康或超重/肥胖成人与儿童摄入非糖甜味剂(NSS)与健康结局的关联。多数结局未见暴露组与非暴露组差异;少数小型短研提示成人BMI与空腹血糖小幅改善,儿童BMI z评分增幅小于糖摄入,但证据确定性多偏低。
要点
- 成人中NSS对BMI与空腹血糖的小幅改善证据确定性极低至低。
- 儿童NSS摄入的BMI z评分增幅小于糖摄入,中等确定性。
- 多数健康结局在NSS暴露与非暴露组间未见差异。
核心结论
- 多数健康结局在NSS暴露与非暴露组间未见差异。
- 纳入研究样本少、持续时间短、方法学与报告质量有限,结果可信度受限。
研究设计与样本
- 遵循Cochrane系统综述方法,检索Medline、Embase、Cochrane CENTRAL、WHO ICTRP、Clinicaltrials.gov及参考文献。
- 纳入标准允许直接比较无摄入或较低NSS摄入与较高NSS摄入,NSS需明确命名、剂量在可接受每日摄入量内、干预至少7天。
主要发现
- 成人BMI平均差异-0.6(95%CI -1.19至-0.01;两项研究,n=174),证据确定性极低至低。
- 成人空腹血糖平均差异-0.16 mmol/L(95%CI -0.26至-0.06;两项研究,n=52)。
- 儿童NSS摄入较糖摄入的BMI z评分增幅更小(-0.15,95%CI -0.17至-0.12;两项研究,n=528,中等确定性)。
- 儿童体重未见显著差异(-0.60 kg,95%CI -1.33至0.14;两项研究,n=467,低确定性)。
关键数值与推荐
- NSS剂量需在可接受每日摄入量内,干预持续时间至少7天。
- 主要结局包括体重或BMI、血糖控制、口腔健康、进食行为、甜味偏好、癌症、心血管疾病、肾脏疾病、情绪、行为、神经认知及不良事件。
临床怎么用
- 现有证据不足以支持NSS对多数健康结局有明确获益或危害。
- 解读NSS相关研究时需考虑样本量小、持续时间短及方法学质量有限。
局限性
- 每个结局纳入的研究数量少,多数研究参与者少、持续时间短。
- 方法学与报告质量有限,导致结果置信度受限。
- 未来研究需采用适当干预时长并详细描述干预、对照与结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the association between intake of non-sugar sweeteners (NSS) and important health outcomes in generally healthy or overweight/obese adults and children. DESIGN: Systematic review following standard Cochrane review methodology. DATA SOURCES: Medline (Ovid), Embase, Cochrane CENTRAL, WHO International Clinical Trials Registry Platform, Clinicaltrials.gov, and reference lists of relevant publications. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Studies including generally healthy adults or children with or without overweight or obesity were eligible. Included study designs allowed for a direct comparison of no intake or lower intake of NSS with higher NSS intake. NSSs had to be clearly named, the dose had to be within the acceptable daily intake, and the intervention duration had to be at least seven days. MAIN OUTCOME MEASURES: Body weight or body mass index, glycaemic control, oral health, eating behaviour, preference for sweet taste, cancer, cardiovascular disease, kidney disease, mood, behaviour, neurocognition, and adverse effects. RESULTS: The search resulted in 13 941 unique records. Of 56 individual studies that provided data for this review, 35 were observational studies. In adults, evidence of very low and low certainty from a limited number of small studies indicated a small beneficial effect of NSSs on body mass index (mean difference -0.6, 95% confidence interval -1.19 to -0.01; two studies, n=174) and fasting blood glucose (-0.16 mmol/L, -0.26 to -0.06; two, n=52). Lower doses of NSSs were associated with lower weight gain (-0.09 kg, -0.13 to -0.05; one, n=17 934) compared with higher doses of NSSs (very low certainty of evidence). For all other outcomes, no differences were detected between the use and non-use of NSSs, or between different doses of NSSs. No evidence of any effect of NSSs was seen on overweight or obese adults or children actively trying to lose weight (very low to moderate certainty). In children, a smaller increase in body mass index z score was observed with NSS intake compared with sugar intake (-0.15, -0.17 to -0.12; two, n=528, moderate certainty of evidence), but no significant differences were observed in body weight (-0.60 kg, -1.33 to 0.14; two, n=467, low certainty of evidence), or between different doses of NSSs (very low to moderate certainty). CONCLUSIONS: Most health outcomes did not seem to have differences between the NSS exposed and unexposed groups. Of the few studies identified for each outcome, most had few participants, were of short duration, and their methodological and reporting quality was limited; therefore, confidence in the reported results is limited. Future studies should assess the effects of NSSs with an appropriate intervention duration. Detailed descriptions of interventions, comparators, and outcomes should be included in all reports. SYSTEMATIC REVIEW REGISTRATION: Prospero CRD42017047668.
引用
- Toews I, Lohner S, Küllenberg de Gaudry D, et al. Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies. BMJ. 2019. PMID: 30602577. doi:10.1136/bmj.k4718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。